April Davis

lumikha ng bagong artikulo

6 d

CD BioGlyco Launches Therapeutic Nucleic Acid Development Platform | #protein #technology

CD BioGlyco Launches Therapeutic Nucleic Acid Development Platform

CD BioGlyco launched its Therapeutic Nucleic Acid Development Platform.

Gusto

Magkomento

Ibahagi

lumikha ng bagong artikulo

21 sa

CD BioGlyco's Glycoprotein Enrichment Platform: Enabling Reliable Detection from Challenging Biological Samples | #health

CD BioGlyco's Glycoprotein Enrichment Platform: Enabling Reliable Detection from Challenging Biological Samples

Glycoproteins are pivotal in disease development, how the immune system reacts to pathogens and cellular communication.

Gusto

Magkomento

Ibahagi

lumikha ng bagong artikulo

51 sa

Glyconanoparticles: A Versatile Platform for Nanobiotechnology Research and Functional Material Design | #biotech #sicence #protein

Glyconanoparticles: A Versatile Platform for Nanobiotechnology Research and Functional Material Design

The integration of carbohydrate chemistry with nanotechnology has led to the emergence of glyconanoparticles—nanomaterials whose surfaces are modified with specific sugar moieties.

Gusto

Magkomento

Ibahagi

Mag-load ng higit pang mga post

Impormasyon

3 mga post
https://www.bioglyco.com/
Babae
Nagtatrabaho sa CD BioGlyco

Tungkol sa

CD BioGlyco is a sub-brand of CD Bio Group. We offer a full range of glycobiology-related products, analysis, custom synthesis, and design to advance your glycobiology research. We have provided professional and reliable scientific research assistance to customers from all over the world and received a lot of appreciation.

Quality and efficiency are our criteria to evaluate ourselves. Our experienced scientists provide quality services using a large number of advanced instruments. We do not subcontract services in order to guarantee high-quality standards.

Mga album

(0)

Sumusunod

(0)

Mga tagasunod

(17)